From the Stroke Center (C.M., G.D., G.B., C.S., A.C., C.W.C.), Neurocenter of Southern Switzerland, Lugano; Stroke Center and Neurology Service (S.N., P.M., C.W.C.), Department of Clinical Neurosciences, Lausanne University Hospital (Centre Hospitalier Universitaire Vaudois); Department of Neurology (M.H., S.J., M.A., U.F.) and Institute of Diagnostic and Interventional Neuroradiology (A.C., J.K.), Institute of Diagnostic, Interventional and Pediatric Radiology, and Department of Neurology, University Hospital Bern and University of Bern, Inselspital; Department of Neurology and Stroke Center (M.M., S.T., H.G., L.H.B.), University Hospital of Basel; Stroke Center (E.C.), Service de Neurologie, HUG, Geneva; Department of Neurology (T.K., K.N.), Cantonal Hospital Aarau; Stroke Center (A.L.), Department of Neurology, University Hospital of Zürich; and Stroke Center (G.K.), Department of Neurology, Cantonal Hospital, St. Gallen, Switzerland.
Neurology. 2019 Oct 22;93(17):e1618-e1626. doi: 10.1212/WNL.0000000000008362. Epub 2019 Oct 7.
To compare outcomes after endovascular therapy (EVT) and IV thrombolysis (IVT) in patients with stroke with emergent large vessel occlusion (LVO) and mild neurologic deficits.
This was a retrospective analysis of patients from the Swiss Stroke Registry with admission NIH Stroke Scale score ≤5 and LVO treated by EVT (± IVT) vs IVT alone. The primary endpoint was favorable functional outcome (modified Rankin Scale [mRS] score 0-1) at 3 months. Secondary outcomes were independence (mRS score 0-2), mRS score (ordinal shift analysis), and survival with high disability (mRS score 4-5). Safety endpoints were mortality and symptomatic hemorrhage.
Of 11,356 patients, 312 met the criteria and propensity score method matched 108 in each group. A comparably large proportion of patients with EVT and IVT had favorable outcome (63% vs 65.7% respectively; odds ratio 0.94, 95% confidence interval 0.51-1.72; = 0.840). Patients with EVT showed a nonsignificant trend toward higher mRS score at 3 months ( = 0.717), while the proportion of surviving patients with high disability was comparably very low in both groups ( = 0.419). Mortality was slightly higher among those with EVT (9.3% vs 2.8%; = 0.06), and symptomatic intracranial hemorrhage was a rare event in both groups (2.8% vs 0%; = 0.997).
In acute ischemic stroke, EVT and IVT appear similarly effective in achieving favorable outcome at 3 months for patients with LVO and mild neurologic symptoms. EVT might be marginally inferior to IVT regarding outcome across all levels of disability and mortality. Further studies are required to determine whether certain subgroups of patients with LVO and mild symptoms benefit from EVT.
This study provides Class III evidence that patients with LVO and mild symptoms receiving either EVT or IVT had similar favorable functional outcomes at 3 months.
比较血管内治疗(EVT)和静脉溶栓(IVT)治疗伴有紧急大血管闭塞(LVO)和轻度神经功能缺损的卒中患者的结局。
这是一项瑞士卒中登记处患者的回顾性分析,纳入的患者入院时 NIH 卒中量表评分≤5 分且 LVO 采用 EVT(±IVT)治疗或单独 IVT 治疗。主要结局为 3 个月时的良好功能结局(改良 Rankin 量表[mRS]评分 0-1)。次要结局为独立(mRS 评分 0-2)、mRS 评分(有序移位分析)和高残疾生存(mRS 评分 4-5)。安全性结局为死亡率和症状性出血。
在 11356 例患者中,312 例符合标准,并通过倾向评分法匹配每组各 108 例。EVT 和 IVT 治疗的患者具有良好结局的比例相当大(分别为 63%和 65.7%;比值比 0.94,95%置信区间 0.51-1.72;P=0.840)。EVT 治疗的患者在 3 个月时的 mRS 评分有升高的趋势,但差异无统计学意义(P=0.717),而两组中高残疾生存患者的比例均非常低(P=0.419)。EVT 治疗组的死亡率略高(9.3% vs. 2.8%;P=0.06),两组的症状性颅内出血均为罕见事件(2.8% vs. 0%;P=0.997)。
在急性缺血性卒中患者中,对于伴有 LVO 和轻度神经症状的患者,EVT 和 IVT 在 3 个月时获得良好结局的效果似乎相似。在所有残疾和死亡率水平上,EVT 可能略逊于 IVT。需要进一步的研究来确定是否存在 LVO 和轻度症状的某些亚组患者从 EVT 中获益。
本研究提供了 III 级证据,表明接受 EVT 或 IVT 治疗的 LVO 和轻度症状患者在 3 个月时具有相似的良好功能结局。